Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study.
Impact of the COVID-19 pandemic on the pharmacological, physical, and psychological treatments of pain: findings from the Chronic Pain & COVID-19 Pan-Canadian Study.
复制标题
DOI：
10.1097/pr9.0000000000000891
复制
发表时间：
2021-01
期刊：
影响因子：
4.8
通讯作者：
Choinière M
中科院分区：
文献类型：
--
作者：
Lacasse A;Pagé MG;Dassieu L;Sourial N;Janelle-Montcalm A;Dorais M;Nguena Nguefack HL;Godbout-Parent M;Hudspith M;Moor G;Sutton K;Thompson JM;Choinière M
2019冠状病毒病大流行对获得药物、身体和心理疼痛治疗产生了重大负面影响，并可能继续产生这种影响。多模式治疗被认为是慢性疼痛（CP）管理的最佳范例。因此，需要在药理学和生理/心理学方法之间保持谨慎的平衡，但这种平衡很容易被破坏。本研究旨在探索COVID-19大流行对CP的药物和物理/心理治疗的影响。2020年4月16日至5月31日期间，在加拿大第一波COVID-19大流行的上升斜坡上，在患有CP的成年人中进行了一项泛加拿大横断面网络研究。共有2864名参与者分享了他们的治疗经验（平均年龄：49.7岁，女性：83.5%）。在药物使用者（n = 2533）中，38.3%报告了药物疼痛治疗的变化。主要原因如下：（1）疼痛症状的变化，（2）无法接触处方医生/取消医疗预约，以及（3）增加药物摄入量以补偿因大流行而停止的身体/心理治疗。在大流行前使用身体/心理疼痛管理方法的参与者中（n = 2467），68.3%不得不修改他们的治疗或自我管理策略。常见的原因是无法使用诊所/健身设施，以及由于与流行病有关的公共卫生安全措施而不得不停止另一种身心治疗，因此需要进行补偿。我们的研究强调了COVID-19大流行对获得疼痛缓解的负面影响，这被认为是一项基本人权。结果将有助于证明资源分配的合理性，并为制定干预措施提供信息，以便为即将到来的浪潮和未来的健康危机做好更好的准备。
The COVID-19 pandemic had, and probably continues having, a significant negative impact on access to pharmacological, physical, and psychological pain treatments. Multimodal treatment is recognized as the optimal paradigm for the management of chronic pain (CP). Careful balance between pharmacological and physical/psychological approaches is thus desirable but can be easily disrupted. This study aimed at exploring the impact of the COVID-19 pandemic on pharmacological and physical/psychological treatments of CP. A Pan-Canadian cross-sectional web-based study was conducted between April 16th and May 31st 2020 among adults living with CP when the country was in the ascending slope of the first COVID-19 pandemic wave. A total of 2864 participants shared their treatment experience (mean age: 49.7 years and women: 83.5%). Among medication users (n = 2533), 38.3% reported changes in their pharmacological pain treatment. The main reasons were as follows: (1) changes in pain symptoms, (2) lack of access to prescribers/cancellation of medical appointments, and (3) increased medication intake in compensation for stopping physical/psychological treatments because of the pandemic. Among participants who used physical/psychological pain management approaches before the pandemic (n = 2467), 68.3% had to modify their treatments or self-management strategies. Common reasons were lack of access to clinics/exercise facilities and the need to compensate for having to stop another type of physical/psychological treatment because of the pandemic-related public health safety measures. Our study underlines the negative impact of the COVID-19 pandemic on access to pain relief, which is considered a fundamental human right. Results will help to justify resource allocation and inform the development of interventions to be better prepared for waves to come and future health crises.